Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma

Hyo Song Kim, Sung Moo Kim, Hyunki Kim, Kyoung Ho Pyo, Jong Mu Sun, Myung Ju Ahn, Keunchil Park, Bhumsuk Keam, Nak Jung Kwon, Hwan Jung Yun, Hoon Gu Kim, Ik Joo Chung, Jong Seok Lee, Kyung Hee Lee, Dae Joon Kim, Chang Geol Lee, Jin Hur, Hyunsoo Chung, Jun Chul Park, Sung Kwan ShinSang Kil Lee, Hye Ryun Kim, Yong Wha Moon, Yong Chan Lee, Joo Hang Kim, Soonmyung Paik, Byoung Chul Cho

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences